Pulling SEC filings + quote and writing the call…

HURCO COMPANIES INC
Next earnings Sep 3, 2026
Last earnings +23.4% on 2026-06-05
Deep-cyclical machine-tool maker in a real downturn, but trades at 0.7x book with net cash and positive cash flow — downside is cushioned, upside needs a cycle turn.
Price / book ~0.7x ($143M cap vs $199M equity) · FY2025
Hurco is a well-run but deeply cyclical CNC machine-tool company caught in a downcycle, and the numbers show it plainly. Revenue has fallen four of the last five years (from $251M in FY2022 to $179M in FY2025) and the company has now posted back-to-back net losses (-$16.6M FY2024, -$15.1M FY2025). Gross margin has compressed to just 18.5% (gross profit -12.6% YoY) and operating margin is negative at -5.8%, so this is not a franchise throwing off earnings today. Management's own MD&A frames the cause as cyclicality plus 'global uncertainty and lower sales volumes,' and it has responded rationally — cutting overhead in FY2024/FY2025, managing inventory, and suspending the quarterly dividend to preserve cash rather than lever up.
What keeps this a hold rather than an avoid is the balance sheet and the price. Stockholders' equity is $199M against a market cap of just $143M, so the stock trades at roughly 0.7x book, with $48.7M of cash (up 46% YoY) and only a token amount of debt. Current assets of $225M dwarf current liabilities of $52M (a ~4.3x current ratio), so there is no solvency or liquidity risk that would force a bad outcome while the cycle plays out. Critically, despite the accounting loss, operating cash flow swung to a positive $17.6M (from ~$2M) as inventory was worked down and capex was cut to $910K — the business is self-funding through the trough. That combination — asset-rich, cash-generative, below book — is the classic deep-value cyclical setup where balance-sheet strength buys time.
Is HURC a buy? The one-page verdict, explained →
HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $235M | $251M | $228M | $187M | $179M |
| Gross profit | $56.2M | $64.5M | $56.2M | $37.7M | $33.0M |
| Operating income | $10.2M | $12.7M | $6.62M | -$8.29M | -$10.3M |
| Net income | $6.76M | $8.23M | $4.39M | -$16.6M | -$15.1M |
| Diluted EPS | $1.01 | $1.23 | $0.66 | -$2.56 | -$2.34 |
| Net margin | 2.9% | 3.3% | 1.9% | -8.9% | -8.5% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Q2 FY26 (Apr 30): sales still soft, but $48.7M cash cushions the downturn
Q2 FY26 (Apr 30): sales still soft, but $48.7M cash cushions the downturn
Annual meeting vote results; directors elected, routine governance items passed
Q1 FY26 filing: cost cuts and inventory management persist through weak demand
Q1 FY26 filing: cost cuts and inventory management persist through weak demand
DEF 14A proxy: board slate, exec pay and auditor up for annual-meeting vote
FY25 10-K: second straight net loss, dividend suspended, tariff/cyclical risks
FY25 10-K: second straight net loss, dividend suspended, tariff/cyclical risks
Officer/director change (Item 5.02) plus Reg FD disclosure; leadership transition
Sources: SEC EDGAR (CIK 0000315374, latest 10-Q filed 2026-06-05) · EODHD · Proprietary analysis · as of 7/3/2026, 4:11:15 PM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 3, 2026, 12:11 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2026-03-12 | DOAR MICHAEL Director | Award | 5.43K | |
| 2026-03-12 | Sivanesan Janaki Director | Award | 5.43K | |
| 2026-03-12 | Rashleger Benjamin Director | Award | 5.43K | |
| 2026-03-12 | Porter Richard R. Director | Award | 5.43K | |
| 2026-03-12 | Keyler Lawrence Director | Award | 5.43K | |
| 2026-03-12 | GARDNER TIMOTHY J Director | Award | 5.43K | |
| 2026-03-12 | Dubin Cynthia S Director | Award | 5.43K | |
| 2025-12-01 | Sivanesan Janaki Director | Buy | 300.00 @ $16.00 | $4.80K |
| 2025-09-03 | Sivanesan Janaki Director | Buy | 550.00 @ $16.50 | $9.07K |
| 2025-09-03 | Sivanesan Janaki Director | Buy | 600.00 @ $16.50 | $9.90K |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1195 tracked peers · median